Hematology is in our blood

Boule Diagnostics AB is a company with a strong heritage when it comes to hematology diagnostics. We developed the very first European blood cell counter, and today our instruments, reagents, calibrators and controls are used by healthcare providers around the world. Boule’s products are currently on sale in more than 100 countries.

Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly important role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary markets.

Boule is listed on NASDAQ Stockholm since June 2011

Introduce Investor Days September 2019

Financial Calendar

Annual report 2019                        2020-04-16

Interim report Q1                           2020-05-07

Annual General Meeting               2020-05-07

Interim report Q2                          2020-08-17

Interim report Q3                          2020-11-05


Welcome to visit us at AACC Annual Scientific Meeting & Clinical Lab Expo, Chicago

28-30 July, Stand no. 4417


Company in figures 2019


Net sales, SEK million
(increased by 18%)


Operating profit, SEK million
(increased by 28%)

0 %

Gross margin
(increased by 0,6%)

0 %

Equity/assets ratio
(decreased by 3%)